Zomedica Pharmaceuticals Corp Net Asset Quality Index
Zomedica Pharmaceuticals Corp net asset quality index. Zomedica Pharmaceuticals Corp (ZOM) has a Net Asset Quality Index of 92.6% as of March 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $142.99 Million minus total liabilities of $10.55 Million yields net assets of $132.44 Million. A higher index indicates a stronger, lower-leverage balance sheet. See Zomedica Pharmaceuticals Corp book value and equity for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Zomedica Pharmaceuticals Corp (2012–2024)
Net asset quality index of Zomedica Pharmaceuticals Corp from 2012 to 2024. This chart shows how Zomedica Pharmaceuticals Corp's Net Asset Quality Index has evolved across 13 annual periods from 2012 to 2024. As of March 2025, the index stands at 92.6%, representing net assets of $132.44 Million against total assets of $142.99 Million USD. Check asset allocation strategy of Zomedica Pharmaceuticals Corp to assess the company's strategic physical and investment asset allocation.
Zomedica Pharmaceuticals Corp Net Asset Quality Index by Year (2012–2024)
Zomedica Pharmaceuticals Corp net asset quality index by year from 2012 to 2024. The table below presents the year-by-year Net Asset Quality Index for Zomedica Pharmaceuticals Corp from 2012 to 2024, covering 13 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Zomedica Pharmaceuticals Corp (ZOM) market capitalisation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 94.4% | $195.66 Million | $207.36 Million | $11.70 Million | ▼ -0.4 pp |
| 2023 | 94.8% | $240.02 Million | $253.20 Million | $13.18 Million | ▼ -0.8 pp |
| 2022 | 95.6% | $267.39 Million | $279.61 Million | $12.22 Million | ▼ -1.0 pp |
| 2021 | 96.6% | $270.89 Million | $280.40 Million | $9.51 Million | ▲ +19.4 pp |
| 2020 | 77.2% | $51.07 Million | $66.14 Million | $15.08 Million | ▲ +27.1 pp |
| 2019 | 50.1% | $2.10 Million | $4.18 Million | $2.09 Million | ▼ -10.5 pp |
| 2018 | 60.6% | $3.66 Million | $6.03 Million | $2.38 Million | ▼ -23.5 pp |
| 2017 | 84.1% | $4.39 Million | $5.22 Million | $828.74K | ▼ -0.7 pp |
| 2016 | 84.8% | $4.13 Million | $4.88 Million | $741.16K | ▼ -11.4 pp |
| 2015 | 96.2% | $3.71 Million | $3.86 Million | $146.29K | ▼ -1.1 pp |
| 2014 | 97.3% | $141.41K | $145.34K | $3.93K | ▼ -0.3 pp |
| 2013 | 97.6% | $206.38K | $211.54K | $5.16K | ▼ -1.4 pp |
| 2012 | 99.0% | $96.34K | $97.31K | $976.80 | — |